Cargando…

Proteomics and network pharmacology of Ganshu Nuodan capsules in the prevention of alcoholic liver disease

INTRODUCTION: Ganshu Nuodan is a liver-protecting dietary supplement composed of Ganoderma lucidum (G. lucidum) spore powder, Pueraria montana (Lour.) Merr. (P. montana), Salvia miltiorrhiza Bunge (S. miltiorrhiza) and Astragalus membranaceus (Fisch.) Bunge. (A. membranaceus). However, its pharmacod...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xiaonan, Wang, Lei, Cui, Xuejie, Zhang, Jing, Liang, Ying, Luo, Zhaojing, Zhou, Bingxue, Jiang, Zheng, Yang, Rachel Y. H., Wu, Yi, Wei, Kunhua, Du, Maobo, Qin, Shuangshuang, Dai, Chen, Zhao, Guoliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547213/
https://www.ncbi.nlm.nih.gov/pubmed/37795374
http://dx.doi.org/10.3389/fendo.2023.1229777
_version_ 1785115013535498240
author Yang, Xiaonan
Wang, Lei
Cui, Xuejie
Zhang, Jing
Liang, Ying
Luo, Zhaojing
Zhou, Bingxue
Jiang, Zheng
Yang, Rachel Y. H.
Wu, Yi
Wei, Kunhua
Du, Maobo
Qin, Shuangshuang
Dai, Chen
Zhao, Guoliang
author_facet Yang, Xiaonan
Wang, Lei
Cui, Xuejie
Zhang, Jing
Liang, Ying
Luo, Zhaojing
Zhou, Bingxue
Jiang, Zheng
Yang, Rachel Y. H.
Wu, Yi
Wei, Kunhua
Du, Maobo
Qin, Shuangshuang
Dai, Chen
Zhao, Guoliang
author_sort Yang, Xiaonan
collection PubMed
description INTRODUCTION: Ganshu Nuodan is a liver-protecting dietary supplement composed of Ganoderma lucidum (G. lucidum) spore powder, Pueraria montana (Lour.) Merr. (P. montana), Salvia miltiorrhiza Bunge (S. miltiorrhiza) and Astragalus membranaceus (Fisch.) Bunge. (A. membranaceus). However, its pharmacodynamic material basis and mechanism of action remain unknown. METHODS: A mouse model of acute alcohol liver disease (ALD) induced by intragastric administration of 50% alcohol was used to evaluate the hepatoprotective effect of Ganshu Nuodan. The chemical constituents of Ganshu Nuodan were comprehensively identified by UPLC-QTOF/MS, and then its pharmacodynamic material basis and potential mechanism of action were explored by proteomics and network pharmacology. RESULTS: Ganshu Nuodan could ameliorate acute ALD, which is mainly manifested in the significant reduction of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in serum and malondialdehyde (MDA) content in liver and the remarkably increase of glutathione (GSH) content and superoxide dismutase (SOD) activity in liver. Totally 76 chemical constituents were identified from Ganshu Nuodan by UPLC-QTOF/MS, including 21 quinones, 18 flavonoids, 11 organic acids, 7 terpenoids, 5 ketones, 4 sterols, 3 coumarins and 7 others. Three key signaling pathways were identified via proteomics studies, namely Arachidonic acid metabolism, Retinol metabolism, and HIF-1 signaling pathway respectively. Combined with network pharmacology and molecular docking, six key targets were subsequently obtained, including Ephx2, Lta4h, Map2k1, Stat3, Mtor and Dgat1. Finally, these six key targets and their related components were verified by molecular docking, which could explain the material basis of the hepatoprotective effect of Ganshu Nuodan. CONCLUSION: Ganshu Nuodan can protect acute alcohol-induced liver injury in mice by inhibiting oxidative stress, lipid accumulation and apoptosis. Our study provides a scientific basis for the hepatoprotective effect of Ganshu Nuodan in acute ALD mice and supports its traditional application.
format Online
Article
Text
id pubmed-10547213
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-105472132023-10-04 Proteomics and network pharmacology of Ganshu Nuodan capsules in the prevention of alcoholic liver disease Yang, Xiaonan Wang, Lei Cui, Xuejie Zhang, Jing Liang, Ying Luo, Zhaojing Zhou, Bingxue Jiang, Zheng Yang, Rachel Y. H. Wu, Yi Wei, Kunhua Du, Maobo Qin, Shuangshuang Dai, Chen Zhao, Guoliang Front Endocrinol (Lausanne) Endocrinology INTRODUCTION: Ganshu Nuodan is a liver-protecting dietary supplement composed of Ganoderma lucidum (G. lucidum) spore powder, Pueraria montana (Lour.) Merr. (P. montana), Salvia miltiorrhiza Bunge (S. miltiorrhiza) and Astragalus membranaceus (Fisch.) Bunge. (A. membranaceus). However, its pharmacodynamic material basis and mechanism of action remain unknown. METHODS: A mouse model of acute alcohol liver disease (ALD) induced by intragastric administration of 50% alcohol was used to evaluate the hepatoprotective effect of Ganshu Nuodan. The chemical constituents of Ganshu Nuodan were comprehensively identified by UPLC-QTOF/MS, and then its pharmacodynamic material basis and potential mechanism of action were explored by proteomics and network pharmacology. RESULTS: Ganshu Nuodan could ameliorate acute ALD, which is mainly manifested in the significant reduction of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in serum and malondialdehyde (MDA) content in liver and the remarkably increase of glutathione (GSH) content and superoxide dismutase (SOD) activity in liver. Totally 76 chemical constituents were identified from Ganshu Nuodan by UPLC-QTOF/MS, including 21 quinones, 18 flavonoids, 11 organic acids, 7 terpenoids, 5 ketones, 4 sterols, 3 coumarins and 7 others. Three key signaling pathways were identified via proteomics studies, namely Arachidonic acid metabolism, Retinol metabolism, and HIF-1 signaling pathway respectively. Combined with network pharmacology and molecular docking, six key targets were subsequently obtained, including Ephx2, Lta4h, Map2k1, Stat3, Mtor and Dgat1. Finally, these six key targets and their related components were verified by molecular docking, which could explain the material basis of the hepatoprotective effect of Ganshu Nuodan. CONCLUSION: Ganshu Nuodan can protect acute alcohol-induced liver injury in mice by inhibiting oxidative stress, lipid accumulation and apoptosis. Our study provides a scientific basis for the hepatoprotective effect of Ganshu Nuodan in acute ALD mice and supports its traditional application. Frontiers Media S.A. 2023-09-18 /pmc/articles/PMC10547213/ /pubmed/37795374 http://dx.doi.org/10.3389/fendo.2023.1229777 Text en Copyright © 2023 Yang, Wang, Cui, Zhang, Liang, Luo, Zhou, Jiang, Yang, Wu, Wei, Du, Qin, Dai and Zhao https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Endocrinology
Yang, Xiaonan
Wang, Lei
Cui, Xuejie
Zhang, Jing
Liang, Ying
Luo, Zhaojing
Zhou, Bingxue
Jiang, Zheng
Yang, Rachel Y. H.
Wu, Yi
Wei, Kunhua
Du, Maobo
Qin, Shuangshuang
Dai, Chen
Zhao, Guoliang
Proteomics and network pharmacology of Ganshu Nuodan capsules in the prevention of alcoholic liver disease
title Proteomics and network pharmacology of Ganshu Nuodan capsules in the prevention of alcoholic liver disease
title_full Proteomics and network pharmacology of Ganshu Nuodan capsules in the prevention of alcoholic liver disease
title_fullStr Proteomics and network pharmacology of Ganshu Nuodan capsules in the prevention of alcoholic liver disease
title_full_unstemmed Proteomics and network pharmacology of Ganshu Nuodan capsules in the prevention of alcoholic liver disease
title_short Proteomics and network pharmacology of Ganshu Nuodan capsules in the prevention of alcoholic liver disease
title_sort proteomics and network pharmacology of ganshu nuodan capsules in the prevention of alcoholic liver disease
topic Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10547213/
https://www.ncbi.nlm.nih.gov/pubmed/37795374
http://dx.doi.org/10.3389/fendo.2023.1229777
work_keys_str_mv AT yangxiaonan proteomicsandnetworkpharmacologyofganshunuodancapsulesinthepreventionofalcoholicliverdisease
AT wanglei proteomicsandnetworkpharmacologyofganshunuodancapsulesinthepreventionofalcoholicliverdisease
AT cuixuejie proteomicsandnetworkpharmacologyofganshunuodancapsulesinthepreventionofalcoholicliverdisease
AT zhangjing proteomicsandnetworkpharmacologyofganshunuodancapsulesinthepreventionofalcoholicliverdisease
AT liangying proteomicsandnetworkpharmacologyofganshunuodancapsulesinthepreventionofalcoholicliverdisease
AT luozhaojing proteomicsandnetworkpharmacologyofganshunuodancapsulesinthepreventionofalcoholicliverdisease
AT zhoubingxue proteomicsandnetworkpharmacologyofganshunuodancapsulesinthepreventionofalcoholicliverdisease
AT jiangzheng proteomicsandnetworkpharmacologyofganshunuodancapsulesinthepreventionofalcoholicliverdisease
AT yangrachelyh proteomicsandnetworkpharmacologyofganshunuodancapsulesinthepreventionofalcoholicliverdisease
AT wuyi proteomicsandnetworkpharmacologyofganshunuodancapsulesinthepreventionofalcoholicliverdisease
AT weikunhua proteomicsandnetworkpharmacologyofganshunuodancapsulesinthepreventionofalcoholicliverdisease
AT dumaobo proteomicsandnetworkpharmacologyofganshunuodancapsulesinthepreventionofalcoholicliverdisease
AT qinshuangshuang proteomicsandnetworkpharmacologyofganshunuodancapsulesinthepreventionofalcoholicliverdisease
AT daichen proteomicsandnetworkpharmacologyofganshunuodancapsulesinthepreventionofalcoholicliverdisease
AT zhaoguoliang proteomicsandnetworkpharmacologyofganshunuodancapsulesinthepreventionofalcoholicliverdisease